RNAZ
TransCode Therapeutics, Inc.NASDAQHealthcare$8.60+4.19%ClosedMarket Cap: $7.9M
As of 2026-04-06
Insider Statistics (Q2 2023)
Purchases
12
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$4.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Dec 22 | CZEREPAK ELIZABETH | director: | Sell | 0 | $0.00 | 0 |
| Mon Dec 22 | STOVER JACK E | director: | Sell | 0 | $0.00 | 0 |
| Tue Jun 18 | Marquet Magda | director | Sell | 70,000 | $1.20 | 70,000 |
| Tue Jun 18 | Manting Erik | director | Sell | 70,000 | $1.20 | 70,000 |
| Tue Jun 18 | Fitzgerald Thomas A | director, officer: Interim CEO, CFO | Sell | 650,000 | $1.20 | 650,000 |
| Tue Jun 18 | Calais Philippe | director | Sell | 70,000 | $1.20 | 70,000 |
| Mon Oct 02 | Fitzgerald Thomas A | director, officer: Chief Financial Officer | Buy | 49,350 | $0.51 | 56,318 |
| Mon Oct 02 | Dudley Robert Michael | director, officer: Chief Executive Officer | Buy | 98,000 | $0.51 | 180,262 |
| Thu Jun 22 | Dudley Robert Michael | director, officer: Chief Executive Officer | Buy | 12,000 | $2.65 | 82,262 |
| Thu Jun 22 | Dudley Robert Michael | director, officer: Chief Executive Officer | Buy | 6,607 | $2.55 | 70,262 |